Products
Investing
Resources
Support
Aurobindo Pharma Limited (AUROPHARMA)
₹1,230.1
INR-16.70(-1.34%)
As of April 30, 2025 8:30:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹74699.80 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹72442.84 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
20.87
Forward P/E
Price to Earnings ratio based on forecasted earnings
20.03
PEG Ratio
Price/Earnings to Growth ratio
20.03
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
2.42
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
58.00%
Operating Margin
Operating income as a percentage of revenue
15.16%
Return on Equity
Net income as a percentage of shareholders' equity
10.63%
Revenue (TTM)
Total revenue over trailing 12 months
₹30921.76 Cr+8.5%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹7067.70 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹59.78-9.700000000000001%
Balance Sheet
Total Cash
Total cash and short-term investments
₹6868.23 Cr
Total Debt
Total short-term and long-term debt
₹8427.25 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
27.29%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1010 - ₹1592
Beta
Measure of stock's volatility compared to the market
0.54
Shares Outstanding
Total number of shares issued by the company
₹58.59 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.25%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.37%
Payout Ratio
Percentage of earnings paid as dividends
2.51%